EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
Aim: to evaluate the efficacy and tolerability of ornithine aspartate, probiotic Bioflorum Forte and their combination with steatosis and steatohepatitis in patients with alcohol and non-alcoholic fatty liver disease. Materials and methods. An open, randomized, comparative clinical study, whic...
Saved in:
Main Authors: | L. Yu. Ilchenko, L. I. Melnikova, M. V. Zhuravleva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2016-10-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/570 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01) -
HYPERAMMONIUM IN PATIENTS WITH PRECIRRHOSIS STAGE: CLINICAL REALITY?
by: L. Yu. Ilchenko, et al.
Published: (2018-06-01) -
Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022-01-01) -
Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01) -
L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A
by: Nourhane Obeid, et al.
Published: (2023-03-01)